Oral supplementation with L-aspartate and L-glutamate inhibits atherogenesis and fatty liver disease in cholesterol-fed rabbit

Amino Acids

Volumn 38, Issue 5, 2010, Pages 1323-1331

  Yanni, Amalia E ^a,b   Agrogiannis, George ^b   Nomikos, Tzortzis ^a   Fragopoulou, Elisabeth ^a   Pantopoulou, Alkisti ^b   Antonopoulou, Smaragdi ^a   Perrea, Despoina ^b  

^a HAROKOPIO UNIVERSITY   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Aspartate; Atherogenesis; Fatty liver disease; Gamma glutamyl transferase; Glutamate

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ASPARTIC ACID; DICARBOXYLIC AMINO ACID; DRINKING WATER; EOSIN; GAMMA GLUTAMYLTRANSFERASE; GLUTAMIC ACID; HEMATOXYLIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; CHOLESTEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATHEROGENESIS; BLOOD CHEMISTRY; BRAIN DAMAGE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CLINICAL EVALUATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE CONTROL; ENZYME ACTIVITY; EXPERIMENTAL RABBIT; FATTY LIVER; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; LIVER INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; ATHEROSCLEROSIS; BLOOD; LIVER FUNCTION TEST; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; RABBIT;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

ADMINISTRATION, ORAL; ANIMALS; ASPARTIC ACID; ATHEROSCLEROSIS; CHOLESTEROL; CHOLESTEROL, DIETARY; FATTY LIVER; GLUTAMIC ACID; LIVER FUNCTION TESTS; MALE; RABBITS; TRIGLYCERIDES;

EID: 77955866815     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-009-0340-x     Document Type: Article

References (38)

1. Behr-Russel D, Rupin A, Simonet S, Bonhomme E, Coumailleu S, Cordi A, Serkiz B, Fabiani JN, Verbeuren TJ (2000) Effect of chronic treatment with the inducible nitric oxide inhibitor L-iminoethyl-L-lysine or with L-arginine on progression of coronary and aortic atherosclerosis in hypercholesterolemic rabbits. Circulation 102(9):1033-1038 (Pubitemid 30656011)
2. Beyreuther K, Biesalski HK, Fernstrom JD, Grimm P, Hammes WP, Heinemann U, Kempski O, Stehle P, Steinhart H, Walker R (2007) Consensus meeting: monosodium glutamate-an update. Eur J Clin Nutr 61:304-313 (Pubitemid 46358769)
3. Birkner E, Zalejska-Fiolka J, Kasperczyk A, Kasperczyk S, Grucka- Mamczar E, Stawiarska-Pieta B, Birkner K (2007) The influence of methionine, selenomethionine and vitamin E on liver metabolic pathways and steatosis in high cholesterol-fed rabbits. Biol Trace Elem Res 120(1-3):179-194 (Pubitemid 350085223)
4. Boger RH, Bode-Boger SM, Mugge A, Kienke S, Brandes R, Dwenger A, Frolich JC (1995) Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis 117(2):273-284
5. Brunt EM, Tiniakos DG (2002) Pathology of steatohepatitis. Best Pract Res Clin Gastroenterol 16(5):691-707
6. Cohn JS, Marcoux C, Davignon J (1999) Detection, quantification and characterization of potentially atherogenic triglyceride reach remnant lipoproteins. Arterioscler Thromb Vasc Biol 19(10): 2474-2486 (Pubitemid 29477850)
7. Fang YL, Liang L, Fu JF (2008) Establishment of rabbit model of juvenile non-alcoholic steatohepatitis. Zhejiang Da Xue Xue Bao Yi Xue Ban 37(3):240-244
8. Finking G, Hanke H (1997) Nikolai Nikolajewitsch Anitschkow (1885-1964) established the cholesterol-fed rabbit as a model for atherosclerosis research. Atherosclerosis 135:1-7 (Pubitemid 27469690)
9. Franci O, Amici A, Margarit R, Merendino N, Picorella E (1996) Influence of thermal and dietary stress on immune response of rabbits. J Anim Sci 74:1523-1529 (Pubitemid 126428734)
10. Fu J, Fang Y, Liang L, Wang C, Hong F, Dong J (2009) A rabbit model for pediatric nonalcoholic steatohepatitis: the role of adiponectin. World J Gastroenterol 15(8):912-918
11. Fujimoto M, Tsuneyama K, Kainuma M, Sekiya N, Goto H, Takano Y, Terasawa K, Selmi C, Eric Gerswin M, Shimada Y (2008) Evidence-based efficacy of Kampo formulas in a model of non-alcoholic fatty liver. Exp Biol Med 233:328-337 (Pubitemid 351328574)
12. Glass CK, Wiztum JL (2001) Atherosclerosis: the road ahead. Cell 104(4):503-516 (Pubitemid 32201946)
13. Grundy SM (2007) Gamma-glutamyl transferase. Another biomarker for metabolic syndrome and cardiovascular risk. Arterioscler Thromb Vasc Biol 27:4-7 (Pubitemid 46360374)
14. Hayashi T, Juliet PA, Matsui-Hirai H, Miyazaki A, Fukatsu H, Funami J, Igutsi A, Ignarro LJ (2005) L-Citrulline and L-arginine supplementation retards the progression of high-cholesteroldiet- induced atherosclerosis in rabbits. Proc Natl Acad Sci USA 102(38):13681-13686 (Pubitemid 41420908)
15. Hozawa A, Okamura T, Murakami Y, Nakamura K, Hayakawa T, Kita Y, Nakamura Y, Okayama A, Ueshima H (2007) c-Glutamyltransferase predicts cardiovascular death among Japanese women. Atherosclerosis 194:498-504 (Pubitemid 47513085)
16. Ihnken K, Morita K, Buckberg GD, Sherman MP, Ignarro LJ, Young HH (1995) Studies on hypoxemic/reoxygenation injury: with aortic clamping XIII. Interaction between oxygen tension and cardioplegic composition in limiting nitric oxide production and oxidant damage. J Thorac Cardiovasc Surg 110:1274-1286
17. Kainuma M, Fujimoto M, Sekiya N, Tsuneyama K, Cheng C, Takano Y, Terasawa K, Shimada Y (2006) Cholesterol-fed rabbit as a unique model of nonalcoholic, nonobese, non-insulin-resistant fatty liver disease with characteristic fibrosis. J Gastroenterol 41:971-980 (Pubitemid 44741410)
18. Kawada N, Otogawa K (2007) Role of oxidative stress and Kupffer cells in hepatic fibrosis. J Gastroenterol 22:S85-S86 (Pubitemid 46848999)
19. King N, McGivan JD, Griffiths EJ, Halestrap AP, Suleiman MS (2003) Glutamate loading protects freshly isolated and perfused adult cardiomyocytes against intracellular ROS generation. J Mol Cell Cardiol 35:975-984 (Pubitemid 36871022)
20. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-
21. Arida A, Yeh M, McCullough AJ, Sanyal AJ, Nonalcoholic Steatohepatitis Clinical Research Network (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41(6):1313-1321 (Pubitemid 40770284)
22. Kolodgie FD, Katocs AS, Largis EE, Wrenn SM, Cornhill JF, Herderick EE, Lee SJ, Virmani R (1996) Hypercholesterolemia in the rabbit induced by feeding graded amounts of low level cholesterol. Arterioscler Thromb Vasc Biol 16:1454-1464
23. Lee DH, Gross MD, Jacobs DR Jr (2004) Association of serum carotenoids and tocopherols with gamma-glutamyl transferase: the cardiovascular risk development in young adults (CARDIA) study. Clin Chem 50:582-588 (Pubitemid 38297309)
24. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, Wang TJ, Benjamin EJ, D'Agostino RB, Vasan RS (2007) Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk-the Framingham Heart Study. Arterioscler Thromb Vasc Biol 27:127-133 (Pubitemid 46360389)
25. Mardini H, Record C (2005) Detection assessment and monitoring of hepatic fibrosis: biochemistry or biopsy? Ann Clin Biochem 42(Pt 6):441-447 (Pubitemid 41640514)
26. Morita K, Ihnken K, Buckberg GD, Matheis G, Sherman MP, Young HH (1995) Studies on hypoxemic/reoxygenation injury: without aortic clamping. VIII. Counteraction of oxidant damage by exogenous glutamate and aspartate. J Thorac Cardiovasc Surg 110(4 Pt 2):1228-1234
27. Paolicchi A, Emdin M, Passino C, Lorenzini E, Titta F, Marchi S, Malvaldi G, Pompella A (2006) b-Lipoprotein and LDLassociated serum c- glutamyltransferase in patients with coronary atherosclerosis. Atherosclerosis 186:80-85
28. Pessayre D (2007) Role of mitochondria in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 22(Suppl 1):S20-S27 (Pubitemid 46848985)
29. Sivakumar R, Anandh Babu PV, Shyamaladevi CS (2008) Protective effect of aspartate and glutamate on cardiac mitochondrial function during myocardial infarction in experimental rats. Chem Biol Interact 176:227-233
30. Walker R (1999) The significance of excursions above the ADI-case study: monosodium glutamate. Regul Toxicol Pharmacol 30:S119-S121
31. Wannamethee SG, Lennon L, Shaper AG (2008) The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes. Atherosclerosis [Epub ahead of print]
32. Yanni AE (2004) The laboratory rabbit: an animal model of atherosclerosis research. Lab Anim (UK) 38:246-256 (Pubitemid 38962073)
33. Yanni AE, Yatzidis HA, Kavantzas NG, Agapitos EV, Perrea DN, Karayannacos PE (2003) Dietary L-aspartate and L-glutamate inhibit fatty streak initiation in cholesterol-fed rabbit. Nutr Metab Cardiovasc Dis 13(2):80-86 (Pubitemid 38569445)
34. Yanni AE, Perrea DN, Yatzidis HA (2005) Effect of antiatherogenic L-aspartate and L-glutamate on serum lipoproteins cholesterol and apolipoproteins A-1 and B in rabbits fed with high cholesterol diet. Nutr Metab Cardiovasc Dis 15:161-165 (Pubitemid 40934159)
35. Yatzidis H (2002) Stable amino acid-based bicarbonate solutions for peritoneal dialysis and hemodialysis. EP 1166787
36. Yen MM, Brunt EM (2007) Pathology of nonalcoholic fatty liver disease. Am J Pathol 128(5):837-847 (Pubitemid 350133997)
37. Yesilova Z, Yaman H, Oktenli C, Ozcan A, Uygun A, Cakir E, Sanisoglu SY, Erdil A, Ates Y, Aslan M, Musabak U, Erbil MK, Karaeren N, Dagalp K (2005) Systemic markers of lipid peroxidation and antioxidants in patients with non-alcoholic fatty liver disease. Am J Gastroenterol 100(4):850-855 (Pubitemid 40592378)
38. Yoko M, Tsunekada E, Kazuo O (2008) Pathologic findings in rabbit models of hereditary hypertriglyceridemia and hereditary postprandial hypertriglyceridemia. Comp Med 58:465-480